Cancer Conferences | Epigenetics Conferences | Epigenetics & Cancer 2018 | Oncology Conferences | Asia | USA | Europe | Middle East | 2019

Quick Links

Epigenetics and Cancer 2018 Deadlines

Epigenetics and Cancer 2018 Student Ambassador

Theme: The Milestones of Scientific Contribution Against Cancer Evolution: Research, Trials, Patient Advocacy & Nursing

Epigenetics and Cancer 2018

Renowned Speakers

Suraiya Rasheed
University of Southern California
USA

Jenny Wang
University of New South Wales
Australia

Manal H Al Khanbashi
Higher College of Technology
Oman

Pedro Sanchez Rovira
Xanit International Hospital
Spain

David A Ligon
Oncology Fox LLC
USA

Atsushi Kaneda
Chiba University
Japan

Ladan Teimoori-Toolabi
Pasteur Institute of Iran
Iran

Sang Hyun Lee
Duke-NUS Medical School
Singapore

Jose Perez Del Palacio
MEDINA Foundation
Spain

Epigenetics and Cancer 2018

Epigenetics and Cancer 2018 conference is mainly focused on the progress of the scientific community (May it be research, clinical trials, and nursing) against Cancer. Hence, it showcases the new scientific and technical advances in comparison to the ancient theories with a vision of advanced innovation.

Who Should Attend??

Epigenetics and Cancer 2018 Conference is a novel discussion to unite overall recognized scholastics in the field of Oncology, Genetics, Epigenetics, Genomics and Proteomics, Bioinformatics, Molecular Biology Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars to exchange about the state of the Research and Development.

Target Audience:

Scientists
Professors
Doctors
Students
Nurses
Patient Advocates
Business delegates

Why Should Attend??

The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on most recent methodologies for concentrating these biological inquiries.

The conference focuses on the wider aspect of the scientific contribution to showcase the new scientific and technical advances in comparison to the ancient theories. Your perspective and our visualization together will set a platform for the exchange of ideas towards contribution to advanced innovation.

We encourage multidisciplinary approach as well. Not only speaker presentations but also workshops, exhibition and networking opportunities are available. A Unique Opportunity for Advertisers and Sponsors at this International event.

Benefits:

All accepted abstracts will be published in the supporting journals of the conference and Conference Book Proceeding.
Each abstract will receive a DOI number provided by Crossref
Opportunity to conduct Workshop with your team members
One to One Interaction with Keynote Speakers, OCM and Eminent personalities for the future course of work.
Opportunity to chair a session.
Certification by the organizing committee.
Individual keynote Page will be created to get more visibility for your scientific research.
Huge Benefits on Group Registration and much more.

Who Should Attend??

Target Audience:

Scientists
Professors
Doctors
Students
Nurses
Patient Advocates
Business delegates

Why Should Attend??

Benefits:

All accepted abstracts will be published in the supporting journals of the conference and Conference Book Proceeding.
Each abstract will receive a DOI number provided by Crossref
Opportunity to conduct Workshop with your team members
One to One Interaction with Keynote Speakers, OCM and Eminent personalities for the future course of work.
Opportunity to chair a session.
Certification by the organizing committee.
Individual keynote Page will be created to get more visibility for your scientific research.
Huge Benefits on Group Registration and much more.

Have Suggesstions? Get 30% OFF on Registrations

Epigenetics and Cancer 2018 is accepting suggestions for the Conference programme.

Persons interested to attend the conference can suggest a topic/session or any speaker that they would like to see in the Conference programme. If the session is selected for the conference program by the committee members, you can stand a chance to avail 30% discount on registration.

Would you like to suggest a session/speaker? Let us know by completing the FORM.

Track 1: Cancer

When the body's control mechanism stops working properly and the cells remain no longer normal, they start growing abnormally and uncontrollably, hence causing Cancer. Old cells do not die and instead grow out of control, forming new, abnormal cells. These extra cells may form a mass of tissue, called a tumor. A tumor can be benign and malignant as well. Benign tumors lack the ability to metastasize whereas malignant are life-threatening and metastasize which leads to cancer.

Global Summit on Oncology & Cancer, March 12-14, 2018 Singapore | Cancer Conferences Japan 2018 | Cancer Genomics Conference: New Era for Cancer Prevention, June 25-26, 2018 Dubai, UAE | Epigenetics Conference 2018 | International Conference on Biomarkers and Cancer Targets, July 16-17, 2018 Dubai, UAE | 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2018 Rome, Italy | Cancer Conferences Middle East 2018 | Cancer Conferences Asia 2018 | 4th International Congress on Epigenetics & Chromatin, September 03-05, 2018 London, UK | 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018 Los Angeles, USA | Cancer Conferences USA 2018 | 15th Asia Pacific Oncologists Annual Meeting, September 5-6, 2018 Tokyo, Japan | 3rd World Congress on Nursing Education & Research, May 16-17, 2018 Montreal, Canada | 26th Cancer Nursing & Nurse Practitioners Conference, July 16-17, 2018 London, UK | 49th Annual Nursing Research and Evidence Based Practice Conference, August 20-21, 2018 Tokyo, Japan | Europe Nursing Conference 2018 | 33rd International Conference on Oncology Nursing and Cancer Care, September 17-18, 2018 Tokyo Japan | 38^th Asia-Pacific Nursing and Medicare Summit, October 03-04, 2018 Osaka, Japan

Asian Societies

European Societies

USA Societies

Track 2: Cancer Evolution

Throughout history, countless causes of cancer have been proposed including: angering the gods, fermenting or acidic lymph, chronic irritation, trauma, and infection. From the Humoral theory in the middle ages to the discovery of DNA structure in the mid-20^th century, science has found many types and the causes of cancer. These theories stood unchallenged until when Galileo and Newton began to use the scientific method, which laid the foundations for the modern scientific study of disease.

Those theories and beliefs have evolved when you fast forward time nearly 200 years to 2012. And the World Health Organization’s International Agency for Research on Cancer (IARC) identified more than 100 chemical, physical, and biological carcinogens (agents that cause cancer by damaging DNA or disrupting cell metabolism).

4th International Congress on Epigenetics & Chromatin, September 03-05, 2018 London, UK | 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018 Los Angeles, USA | Cancer Conferences USA 2018 | 15th Asia Pacific Oncologists Annual Meeting, September 5-6, 2018 Tokyo, Japan | 3rd World Congress on Nursing Education & Research, May 16-17, 2018 Montreal, Canada | Global Summit on Oncology & Cancer, March 12-14, 2018 Singapore | Cancer Conferences Japan 2018 | Cancer Genomics Conference: New Era for Cancer Prevention, June 25-26, 2018 Dubai, UAE | Epigenetics Conference 2018 | International Conference on Biomarkers and Cancer Targets, July 16-17, 2018 Dubai, UAE | 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2018 Rome, Italy | Cancer Conferences Middle East 2018 | Cancer Conferences Asia 2018 | 26th Cancer Nursing & Nurse Practitioners Conference, July 16-17, 2018 London, UK | 49th Annual Nursing Research and Evidence Based Practice Conference, August 20-21, 2018 Tokyo, Japan | Europe Nursing Conference 2018 | 33rd International Conference on Oncology Nursing and Cancer Care, September 17-18, 2018 Tokyo Japan | 38^th Asia-Pacific Nursing and Medicare Summit, October 03-04, 2018 Osaka, Japan

Asian Societies

European Societies

USA Societies

Track 3: Cancer Research and Trials

To identify causes and develop strategies for prevention, diagnosis, treatment, and cure for cancer, the scientific community is indulged in research work all over the world. May it is research centres, institutes, companies, and hospitals, all contributions account a step by step progress against cancer.

Ranging from molecular bioscience to the clinical trials, Cancer research evaluates and compares applications of various Cancer treatments. Surgery, radiation therapy, chemotherapy, hormone therapy, immunotherapy and combined treatment modalities such as chemo-radiotherapy being such applications. The mid-1990s marks the shifting of clinical cancer research to therapies derived from biotechnology research, such as cancer immunotherapy and gene therapy.

The end step in a long process that begins in a research lab is Clinical Trials. After many years of research work to understand its effects on cancer cells in the lab and in animals, a new treatment is used for people in clinical trials.

Through clinical trials, doctors determine whether the new treatments are safe and effective and work better than current treatments. It helps in finding new ways to prevent and detect cancer and also to improve the quality of life for people during and after treatment.

15th Asia Pacific Oncologists Annual Meeting, September 5-6, 2018 Tokyo, Japan | 3rd World Congress on Nursing Education & Research, May 16-17, 2018 Montreal, Canada | Global Summit on Oncology & Cancer, March 12-14, 2018 Singapore | Cancer Conferences Japan 2018 | Cancer Genomics Conference: New Era for Cancer Prevention, June 25-26, 2018 Dubai, UAE | Epigenetics Conference 2018 | 33rd International Conference on Oncology Nursing and Cancer Care, September 17-18, 2018 Tokyo Japan | 38^th Asia-Pacific Nursing and Medicare Summit, October 03-04, 2018 Osaka, Japan | 4th International Congress on Epigenetics & Chromatin, September 03-05, 2018 London, UK | 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018 Los Angeles, USA | Cancer Conferences USA 2018 | | International Conference on Biomarkers and Cancer Targets, July 16-17, 2018 Dubai, UAE | 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2018 Rome, Italy | Cancer Conferences Middle East 2018 | Cancer Conferences Asia 2018 | 26th Cancer Nursing & Nurse Practitioners Conference, July 16-17, 2018 London, UK | 49th Annual Nursing Research and Evidence Based Practice Conference, August 20-21, 2018 Tokyo, Japan | Europe Nursing Conference 2018

Asian Societies

European Societies

USA Societies

Track 4: Cancer Treatment and Therapies

Early treatments focused on improving surgical techniques for removing tumors. It was the 1900s when Radiation therapy and Chemotherapeutics came into the picture and were refined throughout the 20th century.

Emerging topics in cancer treatment research include:

Anti-cancer vaccines
Newer forms of chemotherapy
Gene therapy
Photodynamic therapy
Radiation therapy
Reoviridae (Reolysin drug therapy)
Targeted therapy
Natural killer cells can induce immunological memory

Research is being developed to modify their action against cancer.

Asian Societies

European Societies

USA Societies

Track 5: Cancer Surgery

The removal of tissue from the body is called Surgery. About 60% of patients will undergo some type of surgery to treat their cancer. In some cases, surgery is the only treatment required. It may also be combined with chemotherapy or radiation as part of an overall treatment plan. The place, type, size, stage of cancer and our general health, determine whether surgery is needed.

The several types of cancer surgery are:

Curative surgery
Preventive surgery
Reconstructive surgery
Staging surgery
Supportive surgery
Palliative surgery
Minimally invasive surgery

Asian Societies

European Societies

USA Societies

Track 6: Cancer Genomics and Epigenomics

Cancer genomics is the study of the complete set of DNA sequence and differences between gene expression of tumor cells and normal host cells. It aims to understand the genetic basis of tumor cell proliferation and the evolution of the cancer genome under mutation and selection by the body environment, the immune system and therapeutic interventions. Epigenomics is the study of the total epigenetic modifications on the genetic material of a cell.

Asian Societies

European Societies

USA Societies

Track 7: Epigenetics

The study of heritable changes in gene expression, excluding changes to the basic DNA arrangement (i.e., an adjustment in phenotype without an adjustment in genotype) is called Epigenetics. An epigenetic change is a normal, natural and characteristic occurrence yet can likewise be affected by a few factors including age, the environment/lifestyle, and illness state. Epigenetic modifications can show as normally as the way in which cells terminally separate to differentiate as liver cells, skin cells, etc. Alternately, epigenetic change can have all the more harming impacts that can bring illnesses, disease.

Asian Societies

European Societies

USA Societies

Track 8: Cancer Epigenetics

The study of epigenetic modifications of the Cancer cell genome, which does not bring a change in the nucleotide sequence, is called Cancer Epigenetics. Risk expectation, Prediction and Cancer prevention, growth counteractive actions are also promising and encouraging areas of Epigenetics. A high adequacy of demethylating agents was accounted for essentially in haematological malignancies in view of new conventions with the low dose and long exposure, and their utilization is presently being striven for strong tumors.

During the cell transformation to a cancerous cell, Epigenetic modifications are also important like genetic mutations. Their manipulation brings a great promising approach for prevention, detection, and therapy of Cancer.

Asian Societies

European Societies

USA Societies

Track 9: Epigenomic Effects of Environmental Exposures

Environmental contaminants and toxicants are far reaching all through the world and can incorporate different materials and chemicals, from by results of ignition to contamination trace metals and organic natural mixes utilized as a part of day by day life. Presentation of changing sums and sorts of these contaminants is connected to impacts on human well-being. The fields of natural wellbeing and toxicology have concentrated on bettering the comprehension of how these contaminants affect biological processes so that their wellbeing effects can be lessened or anticipated.

Numerous diseases are brought about by various types of alterations among different genes. Some of these progressions are hereditary changes that are passed along in families while some are mutations that happen due to various hazardous environmental factors.

Asian Societies

European Societies

USA Societies

Track 10: Biomarkers

A biomarker also called biological marker, generally refers to a measurable indicator of some biological state or condition, by which a particular pathological or physiological process, disease, etc., can be identified.

It can be a traceable substance that is introduced into an organism as a means to examine organ function or other aspects of health.

Asian Societies

European Societies

USA Societies

Track 11: Epigenetics Biomarkers in Cancer

A cancer biomarker is a biological marker which indicates the presence of cancer in the body. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers are used for diagnosis, prognosis, and epidemiology of cancer.

Because they are expressed against a person's genetic background and environmental exposure, and epigenetic events occur early in cancer development, Epigenetic biomarkers are more advantageous over other types of biomarkers.

Epigenetic biomarkers potentially have numerous clinical applications in cancer intervention and treatment and significant implications for public health.

Types of epigenetic biomarkers:

DNA methylation, circulating or noncirculating
MicroRNA and other noncoding RNA
Protein markers

For e.g., DNA methylation is one of the major epigenetic mechanisms and it is a genetic feature better reflecting disease development and, consequently, has the potential to become a more conclusive biomarker for detection and diagnosis of different diseases.

Asian Societies

European Societies

USA Societies

In the last few years, the market for Cancer profiling in the Asia-Pacific region has seen huge development as a result of increasing incidence of Cancer, high demand for better healthcare services.

High prevalence of Cancer; expanding R&D subsidizing; expanding power of research exercises; expanding application for non-oncology illnesses; and developing organization between scholarly, biotechnology and pharmaceutical organizations are driving components of the Cancer Genomics and epigenetics market

Cancer Profiling Market is divided into Application, Diagnosis, Technique, Technology etc.

By Application, it consists of :

Diagnostic
Personalized Medicine
Research

By Technique, it consists of :

Genomics
Proteomics
Metabolomics
Epigenetics

By Technology, it consists of :

Next-generation Sequencing
qPCR
In-situ Hybridization
Microarray

It is estimated that the worldwide Cancer Profiling business sector is ready to achieve USD 61.87 Billion by 2021 from USD 25.82 Billion in 2016 according to the "Cancer Profiling Market".The following graph depicts the data pictorially.

Central point powering market development is increasing the number of malignancy cases over the globe.

Components, for example, the expanding interest in personalized medicine and point-of-care diagnostic tests in Cancer profiling are required to offer an extensive variety of development open doors for players in the tumour profiling market. The personalized medicine segment to represent the biggest share of the worldwide cancer profiling application showcase in 2016.

Across the board, continuous research in the part of Epigenetics in diseases and disorders in humans is fuelling the worldwide epigenetics drugs, diagnostic technologies, and indicative advances.

In light of research territories, the market for Epigenetics is fragmented into developmental biology, drug discovery, oncology, and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.

In light of geology, the market of Epigenetics is divided into North America, Europe, Asia, and the Rest of the World. North America is further sub-segmented into the U.S. Furthermore, Canada. In Asia, the degree for this present market's development is extending quickly. Asia represents a large portion of all cancer cases analyzed around the world. This makes helpful conditions for the development of the Epigenetic medications and diagnostics advertise in Asian nations, particularly China, Japan, Australia, and South Korea, with Japan in the prevailing position.

As per the National Cancer Institute, malignancy is among the main sources of death around the world, for which according to a recent review, epigenetic inhibitors comprise of the attributes and capacities which have the potential in cancer prevention and control. This element has given an impulse to the examination directed on epigenetics in the oncology business

In the estimated period between 2015 to 2020, the Epigenetics market is relied upon to stay as the number of new participants in this market will continue ascending with the consistent appearance of new innovations combined with upgraded highlights.

The Asia Pacific market is estimated to witness lucrative growth over the forecast period owing to, the presence of a large prevalence of target diseases and high unmet medical needs. Technology progressions in the field of epigenetics particularly relating to the location of methylation markers identified with growth advancement is relied upon to enhance utilization rates.

Epigenetic reagents were the biggest market esteemed at over USD 1.2 billion in 2014 attributable to the expanding measure of R&D ventures and high utilization rates. Kits are relied upon to increase quick development sought after because of the expanding need for rapid and accurate detection techniques.

DNA methylation was the biggest innovation portion representing more than 47.0% income in 2014. Oncology was the biggest application showcase, with income esteemed at over USD 2.75 billion. The non-oncology segment is anticipated to register the fastest development of over 20.0% during the forecast period. The segment is dominated by metabolic diseases owing to, the growing base of the population suffering from diabetes and organ failure and increasing prevalence of sedentary lifestyle.

Owing to the increasing economic burden of diseases such as cancer and diabetes, governments across the world are advocating the adoption of early disease detection and diagnosis. Early cancer detection, especially, is being encouraged through screening kits. This is helping the development of the worldwide epigenetics drugs and indicative advancements advertise, states the report.

The overall business division of Epigenetics is divided in light of items, research domains, and topography. By item, the business area consolidates catalysts, instruments and consumables, packs and reagents. Instruments and consumables are further sub-segmented into mass spectrometers, cutting-edge sequencers, qPCRs, sonicators and different epigenetics instruments and consumables. Other research zones consolidate expansive managerial instruments and research related to metabolic and inherited diseases.

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)

· Reagents

· Kits

· Instruments

· Enzymes

· Services

Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)

· DNA Methylation

· Histone Methylation

· Histone Acetylation

· Large noncoding RNA

· MicroRNA Modification

· Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)

· Oncology

· Solid Tumors

· Liquid Tumors

· Non-Oncology

· Inflammatory Diseases

· Metabolic Diseases

· Infectious Diseases

· Cardiovascular Diseases

Epigenetics Market Regional Outlook (Revenue, USD Million, 2015 – 2022)

· North America

· USA

· Canada

· Europe

· UK

· Germany

· Asia Pacific

· Japan

· China

· India

· Latin America

· Brazil

· Mexico

· Middle East and Africa (MEA)

· South Africa

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 12-13, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Media Partners

Association with

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

Testimonials

The International Cancer Epigenetics and Biomarkers Conference 2017 in Osaka was an extremely informative and rewarding opportunity of a lifetime to meet with and hear presentations from the best minds in the field. Personally, I am so very grateful to the Conference Organizing Committee and esteemed colleagues I met for surpassing my expectations in such a truly transformative event.
Mr. David A Ligon

I would like to extend my gratitude to your help, support and guidance throughout the formalities and during the conference. I had a very exceptional experience in the conference with all of the speakers and their enriched and enlightening talks. The conference gave me a very excellent chance to collaborate with many scientist and researchers over the world.
Dr. Manal Al Khanbashi

I think the conference took place in a good way but one of the speakers did not come. If we invite more academic people to the conferences it would be more helpful. In other regards the conference and the support team were ok.
Dr. Ladan Teimoori-Toolabi

Thank you for organizing the meeting. I enjoyed interactions with many researchers and got valuable information and connections.
Dr. Masato Yonezawa

2^nd International Conference on Cancer Genetics and Epigenetics November 12-13, 2018 | Radisson Hotel Narita | Tokyo, Japan

Recommended Global Oncology & Cancer Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Epigenetics and Cancer 2018 Deadlines

Epigenetics and Cancer 2018 Student Ambassador

Renowned Speakers

Epigenetics and Cancer 2018

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Association with

Useful Links

Special Issues

Testimonials